BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 11865059)

  • 1. Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors.
    Melnick A; Carlile G; Ahmad KF; Kiang CL; Corcoran C; Bardwell V; Prive GG; Licht JD
    Mol Cell Biol; 2002 Mar; 22(6):1804-18. PubMed ID: 11865059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions.
    Melnick A; Ahmad KF; Arai S; Polinger A; Ball H; Borden KL; Carlile GW; Prive GG; Licht JD
    Mol Cell Biol; 2000 Sep; 20(17):6550-67. PubMed ID: 10938130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B.
    Deltour S; Guerardel C; Leprince D
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14831-6. PubMed ID: 10611298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.
    Huynh KD; Bardwell VJ
    Oncogene; 1998 Nov; 17(19):2473-84. PubMed ID: 9824158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARalpha, and BCL-6.
    Wong CW; Privalsky ML
    J Biol Chem; 1998 Oct; 273(42):27695-702. PubMed ID: 9765306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.
    Guidez F; Ivins S; Zhu J; Söderström M; Waxman S; Zelent A
    Blood; 1998 Apr; 91(8):2634-42. PubMed ID: 9531570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion protein of retinoic acid receptor alpha with promyelocytic leukemia protein or promyelocytic leukemia zinc finger protein recruits N-CoR-TBLR1 corepressor complex to repress transcription in vivo.
    Tomita A; Buchholz DR; Obata K; Shi YB
    J Biol Chem; 2003 Aug; 278(33):30788-95. PubMed ID: 12794076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The integrity of the charged pocket in the BTB/POZ domain is essential for the phenotype induced by the leukemia-associated t(11;17) fusion protein PLZF/RARalpha.
    Puccetti E; Zheng X; Brambilla D; Seshire A; Beissert T; Boehrer S; Nürnberger H; Hoelzer D; Ottmann OG; Nervi C; Ruthardt M
    Cancer Res; 2005 Jul; 65(14):6080-8. PubMed ID: 16024608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein.
    Melnick AM; Westendorf JJ; Polinger A; Carlile GW; Arai S; Ball HJ; Lutterbach B; Hiebert SW; Licht JD
    Mol Cell Biol; 2000 Mar; 20(6):2075-86. PubMed ID: 10688654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein.
    Melnick A; Carlile GW; McConnell MJ; Polinger A; Hiebert SW; Licht JD
    Blood; 2000 Dec; 96(12):3939-47. PubMed ID: 11090081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF.
    Hoatlin ME; Zhi Y; Ball H; Silvey K; Melnick A; Stone S; Arai S; Hawe N; Owen G; Zelent A; Licht JD
    Blood; 1999 Dec; 94(11):3737-47. PubMed ID: 10572087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia.
    Hong SH; David G; Wong CW; Dejean A; Privalsky ML
    Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9028-33. PubMed ID: 9256429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression, purification, characterization, and crystallization of the BTB/POZ domain from the PLZF oncoprotein.
    Li X; Lopez-Guisa JM; Ninan N; Weiner EJ; Rauscher FJ; Marmorstein R
    J Biol Chem; 1997 Oct; 272(43):27324-9. PubMed ID: 9341182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-function studies of the BTB/POZ transcriptional repression domain from the promyelocytic leukemia zinc finger oncoprotein.
    Li X; Peng H; Schultz DC; Lopez-Guisa JM; Rauscher FJ; Marmorstein R
    Cancer Res; 1999 Oct; 59(20):5275-82. PubMed ID: 10537309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression.
    Dhordain P; Lin RJ; Quief S; Lantoine D; Kerckaert JP; Evans RM; Albagli O
    Nucleic Acids Res; 1998 Oct; 26(20):4645-51. PubMed ID: 9753732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The acute promyelocytic leukemia-associated protein, promyelocytic leukemia zinc finger, regulates 1,25-dihydroxyvitamin D(3)-induced monocytic differentiation of U937 cells through a physical interaction with vitamin D(3) receptor.
    Ward JO; McConnell MJ; Carlile GW; Pandolfi PP; Licht JD; Freedman LP
    Blood; 2001 Dec; 98(12):3290-300. PubMed ID: 11719366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein.
    Dhordain P; Albagli O; Lin RJ; Ansieau S; Quief S; Leutz A; Kerckaert JP; Evans RM; Leprince D
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10762-7. PubMed ID: 9380707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of GATA-2 with the promyelocytic leukemia zinc finger (PLZF) protein, its homologue FAZF, and the t(11;17)-generated PLZF-retinoic acid receptor alpha oncoprotein.
    Tsuzuki S; Enver T
    Blood; 2002 May; 99(9):3404-10. PubMed ID: 11964310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
    Grignani F; De Matteis S; Nervi C; Tomassoni L; Gelmetti V; Cioce M; Fanelli M; Ruthardt M; Ferrara FF; Zamir I; Seiser C; Grignani F; Lazar MA; Minucci S; Pelicci PG
    Nature; 1998 Feb; 391(6669):815-8. PubMed ID: 9486655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCoR, a novel corepressor involved in BCL-6 repression.
    Huynh KD; Fischle W; Verdin E; Bardwell VJ
    Genes Dev; 2000 Jul; 14(14):1810-23. PubMed ID: 10898795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.